Document Classification

Section Type: RESULTS

Text: Despite 4-fold higher CD4 + CD25high Treg counts (22. 1 + / -12. 2 % vs. 5. 7 + / -4. 2 % of CD3 + CD4 + T cells), SRL-treated patients, compared to CsA-treated patients, had a significantly higher tubular C4d staining score (1. 1 + / -0. 6 vs. 0. 2 + / -0. 3, P < 0. 01), with nonsignificant trends to higher chronic allograft damage index score (5. 6 + / -2. 4 vs. 3. 7 + / -3. 3), faster GFR (-2. 92 + / -0. 33 vs. -0. 28 + / -0. 44 ml/min/1. 73 m2 per year), and RPF (-10. 80 + / -5. 45 vs. -1. 86 + / -3. 09 ml/min/1. 73 m2 per year) decline, and more clinical proteinuria (n = 6 vs. 4).